FOSTER CITY, Calif. (AP) _ Gilead Sciences Inc. (GILD) on Thursday reported fourth-quarter net income of $1.64 billion.On a per-share basis, the Foster City, California-based company said it had net income of $1.30. Earnings, adjusted for costs related to mergers and acquisitions and non-recurring costs, were $1.67 per share.The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.50 per share.The HIV and hepatitis C drugmaker posted revenue of $7.39 billion in the period, which also topped Street forecasts. Nine analysts surveyed by Zacks expected $6.58 billion.Gilead expects full-year earnings in the range of $6.60 to $7 per share.This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILDCopyright by Automated Insights, Inc. All rights reserved., source Associated Press News